Browse stocks · Browse sectors · Healthcare · Healthcare · Pharmaceuticals & Biotechnology · Pharmaceuticals

NSE RESEARCH WORKSPACE

ERIS Lifesciences Ltd

NSE: ERIS

OverviewFinancial StatementsQuant ScoreForensic Accounting+

Price1Y

Company Overview

ERIS Lifesciences Ltd is classified in Pharmaceuticals.

Market Cap: ₹ 15,198.81 Cr.
Price in snapshot: ₹ 1,095.5
ROE: 19.18 %
ROCE: 14.49 %
Dividend Yield: 0.65 %

Snapshot updated 22 July 2026. Figures are not live quotes.

Research coverage

Concall documents: transcript for Q2 FY27, dated 29 October 2026.
Annual-report coverage: FY2025.
Company exchange-filing catalog coverage.

Browse concall documents · Browse exchange filings